Pengobatan Resistensi Antipsikotik Pada Pasien Skizofrenia
DOI:
https://doi.org/10.47861/usd.v2i1.647Keywords:
schizophrenia, resistant, antipsychoticAbstract
Schizophrenia is a disorder with a heterogeneous etiology that includes patients with varying clinical presentations, responses to therapy and disease courses. One therapy for treating schizophrenic patients is to use typical and atypical antipsychotics. However, patients who initially respond to antipsychotic drugs can become resistant (Treatment Resistance Schizophrenia).
References
Domenico De Berardis, Gabriella Rapini, Luigi Olivieri, Domenico Di Nicola, Carmine Tomasetti, Alessandro Valchera, Michele Fornaro, Fabio Di Fabio, Giampaolo Perna, Marco Di Nicola, Gianluca Serafini, Alessandro Carano, Maurizio Pompili, Federica Vellant, G. M. and M. D. G. (2018). Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine. Therapeutic Advances in Drug Safety, 9(6), 259–261. https://doi.org/10.1177/https
Fanani, H. M. (2013). Perbedaan Keefektifan antara Clozapine (Clorilex) dengan Electro Convulsive Therapy (ECT) dalam Penatalaksanaan Skizofrenia Resisten Obat di Rumah Sakit Jiwa Daerah Surakarta. Wacana, 5(2), 1–16.
Howes, OD, McCutcheon, R, Agid, O, de Bartolomeis, A, van Beveren, NJ, Birnbaum, ML, Bloomfield, MA, Bressan, RA, Buchanan, RW, Carpenter, WT, Castle, DJ, Citrome, L, Daskalakis, ZJ, Davidson, M, Drake, RJ, Dursun, S, Ebdrup, BH, Elkis, H, Falkai, P, Flei. (n.d.).
Lally, J., & Gaughran, F. (2019). Treatment resistant schizophrenia - Review and a call to action. Irish Journal of Psychological Medicine, 36(4), 279–291. https://doi.org/10.1017/ipm.2018.47
Machmud, S. (2017). Efektifitas Sodium Divalproat Sebagai Terapi Adjuvan Terhadap Perbaikan Gejala Positif Skizofrenia Paranoid yang Diberi Haloperidol. Program Studi Biomedik, Universitas Hasanuddin.
Maslim, R. (2007). Penggunaan Klinis Obat Psikotropik. Edisi Ketiga. Jakarta: Bagian Ilmu Kedokteran Jiwa FK Unika Atma Jaya, 23–30.
Natasha Syifa Rachman, Siti Annisa Devi Trusda, & Dede Setiapriagung. (2021). Clozapine Effektif pada Pasien Skizofrenia yang Resisten terhadap Pengobatan. Bandung Conference Series: Medical Science, 1(1), 1–5. https://doi.org/10.29313/bcsms.v1i1.67
Oktaviani, D. J., Widiyastuti, S., Maharani, D. A., Amalia, A. N., Ishak, A. M., & Zuhrotun, A. (2020). REVIEW ARTIKEL : FARMAKOTERAPI DAN REHABILITASI PSIKOSOSIAL PADA. Farmaka, 18(1), 1–15.
Padmasari, S., & Sugiyono. (2017). Evaluasi Rasionalitas Penggunaan Obat Antipsikotik Pada Pasien Skizofrenia di Instalasi Rawat Inap Rumah Sakit Jiwa Grhasia Yogyakarta Tahun 2017. Acta Holist. Pharm, 1(1), 25–32.
Polese, D., Fornaro, M., Palermo, M., De Luca, V., & De Bartolomeis, A. (2019). Treatment-resistant to antipsychotics: A resistance to everything? Psychotherapy in treatment-resistant schizophrenia and nonaffective psychosis: A 25-year systematic review and exploratory meta-analysis. Frontiers in Psychiatry, 10(MAR). https://doi.org/10.3389/fpsyt.2019.00210
Potkin, S. G., Kane, J. M., Correll, C. U., Lindenmayer, J. P., Agid, O., Marder, S. R., Olfson, M., & Howes, O. D. (2020). The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research. Npj Schizophrenia, 6(1). https://doi.org/10.1038/s41537-019-0090-z
Rumagit, P., Tampa’i, R., Pareta, D., & Tombuku, J. (2021). Potensi Interaksi Obat Antipsikotik Pada Pasien Skizofrenia Paranoid di Rumah Sakit Jiwa Prof. Dr.V.L Ratumbuysang. Jurnal Biofarmasetikal Tropis, 4(1), 88–96.
Sadock BJ, Sadock VA. Kaplan & Sadocks Synopsis Of Psychiatry : Behavioral Sciences/Clinical Psyciatry: 11th Edition. Lippincot Wiliams & Wilkins. USA : A Wolter Kluwer Company (2015). (n.d.).
Yulianty, M. D., Cahaya, N., & Srikartika, V. M. (2017). Studi Penggunaan Antipsikotik dan Efek Samping pada Pasien Skizofrenia di Rumah Sakit Jiwa Sambang Lihum Kalimantan Selatan. Jurnal Sains Farmasi & Klinis, 3(2), 153. https://doi.org/10.29208/jsfk.2017.3.2.108
